High Tower Advisors, LLC Pro Phase Labs, Inc. Transaction History
High Tower Advisors, LLC
- $71.3 Billion
- Q1 2025
A detailed history of High Tower Advisors, LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 229,454 shares of PRPH stock, worth $78,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
229,454
Previous 236,781
3.09%
Holding current value
$78,014
Previous $179,000
49.16%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PRPH
# of Institutions
37Shares Held
4.95MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT1.53MShares$518,7070.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$138,8100.0% of portfolio
-
Four World Capital Management LLC New York, NY377KShares$128,0360.1% of portfolio
-
Quinn Opportunity Partners LLC Charlottesville, VA318KShares$108,1630.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny300KShares$101,9350.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $5.45M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...